ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
LivaNova PLC

LivaNova PLC (LIVN)

51.30
-0.99
(-1.89%)
Closed July 30 4:00PM
51.45
0.15
( 0.29% )
Pre Market: 8:00AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
51.45
Bid
51.33
Ask
80.00
Volume
288
0.00 Day's Range 0.00
42.75 52 Week Range 64.475
Market Cap
Previous Close
51.30
Open
-
Last Trade
1
@
51.6
Last Trade Time
08:03:01
Financial Volume
-
VWAP
-
Average Volume (3m)
655,784
Shares Outstanding
54,151,745
Dividend Yield
-
PE Ratio
156.45
Earnings Per Share (EPS)
0.33
Revenue
1.15B
Net Profit
17.75M

About LivaNova PLC

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients healthcare prof... LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients healthcare professionals and healthcare systems. At LivaNova we understand the importance of bringing both clinical and economic value to our customers. We are a strong market-leading medical technology and services company offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol LIVN. LivaNova has approximately 3000 employees worldwide. We are headquartered in London UK and maintain a presence in more than 100 countries. LivaNova is a worldwide leader in advanced circulatory support cardiopulmonary and neuromodulation dedicated to creating meaningful products and therapies that transform lives each and every day. Show more

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Headquarters
London, Gbr
Founded
1970
LivaNova PLC is listed in the Electromedical Apparatus sector of the NASDAQ with ticker LIVN. The last closing price for LivaNova was $51.30. Over the last year, LivaNova shares have traded in a share price range of $ 42.75 to $ 64.475.

LivaNova currently has 54,151,745 shares outstanding. The market capitalization of LivaNova is $2.78 billion. LivaNova has a price to earnings ratio (PE ratio) of 156.45.

LivaNova (LIVN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-7k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

LIVN Latest News

Protagonist Therapeutics Set to Join S&P SmallCap 600

Protagonist Therapeutics Set to Join S&P SmallCap 600 PR Newswire NEW YORK, June 27, 2024 NEW YORK, June 27, 2024 /PRNewswire/ -- Protagonist Therapeutics Inc. (NASD: PTGX) will replace...

Turnstone Biologics Appoints William Waddill to its Board of Directors

SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.05-5.5963302752354.555.4849.1388227652.29248591CS
4-1.44-2.7226318774852.8955.5849.1375817852.42746519CS
12-11.29-17.994899585662.7463.5749.1365578454.67416902CS
261.482.9617770662449.9764.47547.7969428154.83205941CS
52-6.38-11.032336157757.8364.47542.7557359253.04742182CS
156-34.25-39.964994165785.793.8940.2647035858.59655938CS
260-22.07-30.019042437473.5293.8933.446887260.20652405CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MHUAMeihua International Medical Technologies Company Ltd
$ 1.83
(77.67%)
12.27M
NUZENuZee Inc
$ 6.08
(64.32%)
4.05M
FRESFresh2 Group Ltd
$ 3.25
(55.50%)
59
PMECPrimech Holdings Ltd
$ 0.80
(52.03%)
10.14M
STECSantech Holdings Limited
$ 0.3783
(32.50%)
17
FGENFibroGen Inc
$ 0.5725
(-44.42%)
597.76k
IMNNImunon Inc
$ 1.92
(-42.17%)
1.77M
MGNXMacroGenics Inc
$ 4.11
(-21.71%)
246.92k
TTNPTitan Pharmaceuticals Inc
$ 4.52
(-19.43%)
29
ERASErasca Inc
$ 2.60
(-19.00%)
11.99k
FFIEFaraday Future Intelligent Electric Inc
$ 0.3787
(19.84%)
29.05M
BNOXBionomics Ltd
$ 1.00
(19.89%)
12.48M
MHUAMeihua International Medical Technologies Company Ltd
$ 1.83
(77.67%)
12.27M
PMECPrimech Holdings Ltd
$ 0.80
(52.03%)
10.14M
NVDANVIDIA Corporation
$ 110.88
(6.89%)
9.88M

Discussion

View Full Feed
MartinLutherKing MartinLutherKing 5 minutes ago
Results must be a failure,
RNAZ
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 5 minutes ago
$TANH (@$.25) >>> Time to reload!? #Reversal #Overreaction

https://www.stockscores.com/chart.asp?TickerSymbol=tanh&TimeRange=60&Interval=60&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=830&ChartHeight=500&LogScale=None&Band=BB&avgType1=SMA&movAvg1=20&avgType2=SMA&movAvg2
TANH
MartinLutherKing MartinLutherKing 6 minutes ago
They already started trials
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15 2024 - 9:00AM


Share On Facebook

TransCode Therapeutics, Inc. (NASDAQ: RNA
RNAZ
show_me_money show_me_money 6 minutes ago
Same. Might add here. Watching for the first hour probably.
INM
100% CORRECT DD 100% CORRECT DD 6 minutes ago
Can we take a vote? How many here appreciate the thousands of hours of documentation and found it very useful over the years? Without that effort, I don't know where we would be today!
PTOI
LandPro LandPro 6 minutes ago
It smells worse than the Wuhan fish market here—trips soon, which should not be a surprise to anyone who actually did their due diligence.
IGPK
Al 100 Al 100 6 minutes ago
Of course they are payed, 💯 %
GME
Awl416 Awl416 7 minutes ago
What leaked?
NCNC
shapeman shapeman 7 minutes ago
There is no news. There is no update.

Why do you guys keep doing this?

No one on this forum has ever presented anything solid or verifiable. What I can’t figure out is why are Willy and TPP yanking our chain all the time? Why can’t you just let it go?

MadBadger MadBadger 7 minutes ago
Newflow, thank you for sharing.
COOP
Awl416 Awl416 8 minutes ago
Oh boy
MHUA
100lbStriper 100lbStriper 8 minutes ago
$NLST Interesting comments from Jason Sheasby in this interview regarding 417 in relation to the 912. PTAB is invalidating high value patents!

It’s all about personality
‘It’s all about personality’: Co-counsel for Netlist on their ‘high-wire act’
Netlist’s recent $44
NLST
AKATITUS AKATITUS 8 minutes ago
6th ones the charm
😄
SBFM
jimmybob jimmybob 8 minutes ago
SPY almost $548 sweet molasses
kabunushi kabunushi 9 minutes ago
Check the form 4 again. What does it show as the transaction date? What was the closing price that day (also near the lod)?

The transaction was dated 7/26, Friday. I'm guessing that JJ agreed to pay Friday's closing price.
NWBO
Hosai Hosai 9 minutes ago
Apologies I shouldn't have said no drop outs at week 36 - 48 in dosed there were still some but at lowest rate. Placebo had highest drop out week 36-48 and was at same level as 50mg group for weeks 24-36.
AVXL
tdbowieknife tdbowieknife 9 minutes ago
No... Making one itty-bitty payment ... Greg Mitchell STILL has not admitted to the Pretzel Haus lawsuit and 233,674.48-dollar Judgment. There are many other debt that are going unpaid. Grillit is in debt to around a million bucks to toxic lenders, and who knows what else Greg Has not disclosed.
GRLT
chilar4567 chilar4567 9 minutes ago
I'm beginning to think FDA approval is just a pipe dream.
BABYF
cloudera cloudera 9 minutes ago
Assuming we are status quo in next quarter, Our revenue for the next quarter will be $67.5 minus $15 from China minus 1/3 loss of revenue from PBM. It looks live we will see a loss of $8M next quarter? [(67.5 -15 - 1/3(67.5-15)) = $35 - 43.3 = -8.3]
PBM
WeTheMarket WeTheMarket 10 minutes ago
Plug Power webinar "Hydrogen: Facts vs. Fiction" today at 12:00 PM ET
Register at https://event.on24.com/wcc/r/4646223/6A711449FB0745E74159CEEAEBDC1066?partnerref=CorpEventsPg

Background
Despite reality and the advances that have been made with hydrogen, there are still
NKLA
prototype_101 prototype_101 10 minutes ago
Ha!! Too funny!! it's a DEVELOPMENT contract, it's NOT a commercial contract

so good for them, they need something to do to keep themselves busy trying to stabilize their fragile molecules, the cross-linking is helping but it is NOT enough for commercial applications!!!!
LWLG
WeTheMarket WeTheMarket 10 minutes ago
Plug Power webinar "Hydrogen: Facts vs. Fiction" today at 12:00 PM ET
Register at https://event.on24.com/wcc/r/4646223/6A711449FB0745E74159CEEAEBDC1066?partnerref=CorpEventsPg

Background
Despite reality and the advances that have been made with hydrogen, there are still
FCEL
subslover subslover 11 minutes ago
Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy
YANGZHOU, China, July 31, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class
MHUA
WeTheMarket WeTheMarket 11 minutes ago
Reminder, Plug Power webinar "Hydrogen: Facts vs. Fiction" today at 12:00 PM ET
Register at https://event.on24.com/wcc/r/4646223/6A711449FB0745E74159CEEAEBDC1066?partnerref=CorpEventsPg

Background
Despite reality and the advances that have been made with hydrogen, there
PLUG
Skipperdog11 Skipperdog11 12 minutes ago
RMB- I think delisting is not a terrible fate when you consider that this company will soon be in a battle to remain north of the $100m / year in total revenues. The business plan seems to be to keep the spend to an absolute minimum while time is bought for the progress of getting row onboard and s
AMRN

Your Recent History

Delayed Upgrade Clock